Molecular Partners AG (XSWX:MOLN)
CHF 3.305 -0.115 (-3.36%) Market Cap: 108.63 Mil Enterprise Value: -74.61 Mil PE Ratio: 0 PB Ratio: 0.64 GF Score: 53/100

Molecular Partners AG at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 12:30PM GMT
Release Date Price: CHF24.5 (+10.11%)
Richard Vosser
JPMorgan Chase & Co, Research Division - Senior Analyst

Welcome to the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to host Patrick Amstutz, the CEO of Molecular Partners for this session. Before I hand over to Patrick for the presentation, I'd just remind everyone that they can ask their questions on the website for the conference, and then I'll ask them when we get to that part of the session. With that, Patrick, welcome to the conference. Good to see you. Over to you.

Patrick Amstutz
Molecular Partners AG - Co-Founder, CEO, Member of Management Board & Director

Thanks, Richard. And unfortunately, this is not in person. I was really very much planning to be at JPMorgan in San Francisco. That is a big -- it's very a -- shame that we can't do that. Our reason is clear. It's still COVID times. And part of my speech will be also be about that. With the benefit being, I think, it's one of the conferences where I'm leased jet lagged.

My name is Patrick

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot